How should we manage highly morbid forms of chronic GvHD?

During the 2021 TCT Meetings Digital Experience, the GvHD Hub spoke to Daniel Wolff, University Hospital Regensburg, Regensburg, DE. We asked, How should we manage highly morbid forms of chronic GvHD?

In this video, Wolff discusses the challenges and treatment approaches of highly morbid forms of chronic graft-versus-host disease (GvHD) for different affected organs. Wolff is hopeful that, over the coming years, new agents and clinical trials will achieve significant progress in this area.